ELISA Kit for Angiotensin 1-7 (Ang1-7)
CES085MI
Product group Assays
Product CES085MI is not available
Product not available
There may be an alternative product available, please contact our technical support team.
Overview
- SupplierCloud-Clone Corp.
- Product NameELISA Kit for Angiotensin 1-7 (Ang1-7)
- Delivery Days Customer9
- Assay Detection Range9.88-800pg/mL
- Assay PrecisionIntra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Angiotensin 1-7 (Ang1-7) were tested 20 times on one plate, respectively. Inter-assay Precision (Precision between assays): 3 samples with low, middle and ...
- Assay SensitivityThe minimum detectable dose of this kit is typically less than 4.34pg/mL
- Assay Test PrincipleThis assay employs the competitive inhibition enzyme immunoassay technique. A monoclonal antibody specific to Angiotensin 1-7 (Ang1-7) has been pre-coated onto a microplate. A competitive inhibition reaction is launched between biotin labeled ...
- Assay Time2h
- CertificationResearch Use Only
- UNSPSC41116158
References
- Li Y, Song J, Jiang Y, et al. Ang-(1-7) protects skeletal muscle function in aged mice. BMC Musculoskelet Disord. 2021,22(1):809. doi: 10.1186/s12891-021-04693-9Read this paper
- Xu H, An X, Tian J, et al. Angiotensin-(1-7) protects against sepsis-associated left ventricular dysfunction induced by lipopolysaccharide. Peptides. 2021,144:170612. doi: 10.1016/j.peptides.2021.170612Read this paper
- Kozakiewicz M, Slomko J, Buszko K, et al. Acute Biochemical, Cardiovascular, and Autonomic Response to Hyperbaric (4 atm) Exposure in Healthy Subjects. Evid Based Complement Alternat Med. 2018,2018:5913176. doi: 10.1155/2018/5913176Read this paper
- Chen QF, Kuang XD, Yuan QF, et al. Lipoxin A(4) attenuates LPS-induced acute lung injury via activation of the ACE2-Ang-(1-7)-Mas axis. Innate Immun. 2018,24(5):285-296. doi: 10.1177/1753425918785008Read this paper
- Liu Z, Liu J, Xiao M, et al. Mesenchymal stem cell-derived microvesicles alleviate pulmonary arterial hypertension by regulating renin-angiotensin system. J Am Soc Hypertens. 2018,12(6):470-478. doi: 10.1016/j.jash.2018.02.006Read this paper
- Tada Y, Yagi K, Uno M, et al. Improvement of Plasma Biomarkers after Switching Stroke Patients from Other Angiotensin II Type I Receptor Blockers to Olmesartan. J Stroke Cerebrovasc Dis. 2015,24(7):1487-92. doi: 10.1016/j.jstrokecerebrovasdis.2015.03.015Read this paper


